News
News

The latest updates from AFAR.

Board member in the News: David Sinclair receives NIH Directors High Risk, High Reward award

Oct 9
2017

Board member in the News: David Sinclair receives NIH Directors High Risk, High Reward award View MoreBACK

On October 5, 2017, the National Institutes of Health (NIH) Common Fund's High Risk, High Reward program announced that 2000 AFAR Research Grant recipient and current Board Member David Sinclair, PhD, has received its NIH Directors Pioneer Award for his project, Uncovering the Human Secretome.

Dr. Sinclair is one of 12 Pioneer Awards. The High-Risk, High-Reward Research program, part of the NIH Common Fund, funds 86 awards to exceptionally creative scientists proposing to use highly innovative approaches to tackle major challenges in biomedical research. The program supports high-risk ideas with high-impact potential. The program accelerates scientific discovery by supporting high-risk research proposals that may not fare well in the traditional peer review process despite their potential to advance the field. Applicants of the program are encouraged to think outside-the-box and to pursue exciting, trailblazing ideas in any area of research relevant to the NIH mission.

Learn more about Dr. Sinclair’s NIH Directors Pioneer Award project here.
 


David A. Sinclair, PhD is as a Professor of Genetics and co-Director of the Paul F. Glenn Laboratories for the Biological Mechanisms of Aging at Harvard Medical School.





View MoreBACK TO TOP